IconOVir Bio, Inc. — Form D/A
IconOVir Bio, Inc. of New York, NY, a company, filed a Form D amendment with the SEC on 2024-06-04. The offering totals $20.2M, of which $20.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-06-04
- Form: D/A
- Accession: 0001437749-24-019217
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.2M
- Amount sold: $20.2M
- Investors: 34
- Date of first sale: 2023-06-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-484703
Issuer
- Name: IconOVir Bio, Inc.
- CIK: 0001834886
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 689 Fifth Avenue, New York, NY, 10022
- Phone: 852-922-9594
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| David A Chang | Director | New York, NY |
| William S Kaelin | Director | New York, NY |
| Joshua A Kazam | Director | San Mateo, CA |
| Helen S Kim | Director | Menlo Park, CA |
| Jakob S Loven | Director | New York, NY |
| Mark A McCamish | Director | New York, NY |
| Sean A Algeo | Executive Officer | New York, NY |
| John A Huynh | Executive Officer | New York, NY |
| Julie A Maltzman | Executive Officer | New York, NY |
| Mark A McCamish | Executive Officer | New York, NY |
| Heba M Nowyhed | Executive Officer | New York, NY |
| David M Tanen | Executive Officer | New York, NY |
| Nicole M van de Leuv | Executive Officer | New York, NY |
| Sean A Algeo | Promoter | New York, NY |
| David A Chang | Promoter | New York, NY |
| Joshua A Kazam | Promoter | San Mateo, CA |
| David M Tanen | Promoter | New York, NY |
| Arie S Belldegrun | Director | New York, NY |
| Arie S Belldegrun | Promoter | New York, NY |
| Sean M Algeo | Executive Officer | New York, NY |
| Sean M Algeo | Promoter | New York, NY |
| Jakob A Loven | Director | New York, NY |
| David S Chang | Director | Houston, TX |
| David S Chang | Promoter | Houston, TX |
Other filings by this issuer (2)
More